A study on ear damage caused by anti-cancer drug (Cisplatin)- to find out the number of cases and the risk factors for occurrence of ear damage caused by the drug.
Not Applicable
- Conditions
- Health Condition 1: C801- Malignant (primary) neoplasm, unspecified
- Registration Number
- CTRI/2023/05/053252
- Lead Sponsor
- KASTURBA MEDICAL COLLEGE, MANIPA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Malignancy patients going to start Cisplatin treatment.
Exclusion Criteria
Head and neck malignancy patients with Radiotherapy treatment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method